Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment ContinuesPromising Data, including a 59% Stable ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

Bill Gates criticized fellow tech billionaire Elon Musk for promoting far-right politics not just in the United States but around the world ― and urged other nations to take action to limit the ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...

The team discovered a unique population of immune cells that is important to the successful treatment of relapsed acute myeloid leukemia (AML). This investigation was done in partnership with the ...

In a paper published today in Science Immunology, the team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML).

A massive blast ripped through an ordnance factory near Nagpur this morning, killing eight workers and injuring seven others. The blast occurred in the Bhandara district of Maharashtra.

The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). A research team from Columbia Engineering and ...

The findings were published in Science Immunology. "Relapse of AML after stem cell transplant is a major challenge," says first author Katie Maurer, MD, Ph.D.. "There are few effective therapies ...

She previously spent nearly two decades at Citi, most recently as managing director and chief compliance officer of AML and BSA, according to her LinkedIn. Since joining TD, she has “driven critical ...

AML = Acute myeloid leukemia; CK = Complex karyotype; ECOG = Eastern Cooperative Oncology Group; EORTC = European Organization for Research and Treatment of Cancer; GIMEMA = Italian Group for ...